Who Owns CNTX?

Context Therapeutics Inc. — Institutional Ownership & 13F Holdings

$2.33

+0.07 (+3.32%)

Market Cap

$271.5M

Shares Outstanding

91,879,177

Institutional Holders

43

Total Inst. Value

$43.7M

% of Float Held

109.9%

QoQ Holder Change

+19

Institutional data as of Q1 2025

New Positions

4

Closed Positions

14

Increased

7

Decreased

13

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1MPM BioImpact LLC$9.0M14,705,882
2Avidity Partners Management LP$4.6M7,477,200
3Nextech Invest, Ltd.New$4.5M7,419,355
4Deep Track Capital, LP$4.5M7,419,355
5Blue Owl Capital Holdings LP$4.5M7,367,906
6GREAT POINT PARTNERS LLC$2.9M4,683,711
7FRANKLIN RESOURCES INC$2.5M4,003,380
8VANGUARD GROUP INC$2.0M3,253,467
9Blackstone Inc.$1.5M2,440,330
10Nantahala Capital Management, LLC$1.2M1,935,484

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CNTX?

As of Q1 2025, 43 institutional investors report holding CNTX (Context Therapeutics Inc.) in their 13F filings.

What percentage of Context Therapeutics Inc. is owned by institutions?

Institutional investors hold approximately 109.9% of Context Therapeutics Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most CNTX?

The largest institutional holder of CNTX is MPM BioImpact LLC with $9.0M in shares.

Are institutions buying or selling CNTX?

This quarter, 4 institutions opened new positions in CNTX and 14 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.